A241820 Stock Overview
Provides multiplex in vitro diagnostic (IVD) products and platform services. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
PCL, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩675.00 |
| 52 Week High | ₩4,385.00 |
| 52 Week Low | ₩666.00 |
| Beta | 0.061 |
| 11 Month Change | -35.65% |
| 3 Month Change | -53.99% |
| 1 Year Change | -82.47% |
| 33 Year Change | -94.90% |
| 5 Year Change | -75.06% |
| Change since IPO | -77.89% |
Recent News & Updates
Recent updates
Did You Miss PCL's (KOSDAQ:241820) Impressive 208% Share Price Gain?
Mar 16
Is PCL (KOSDAQ:241820) Using Too Much Debt?
Feb 17
PCL, Inc. (KOSDAQ:241820) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?
Jan 27We're Not So Sure You Should Rely on PCL's (KOSDAQ:241820) Statutory Earnings
Jan 06Is PCL's (KOSDAQ:241820) Share Price Gain Of 249% Well Earned?
Dec 16Do Institutions Own PCL, Inc. (KOSDAQ:241820) Shares?
Nov 25Shareholder Returns
| A241820 | KR Medical Equipment | KR Market | |
|---|---|---|---|
| 7D | -11.1% | 8.1% | 2.9% |
| 1Y | -82.5% | 11.5% | -2.8% |
Return vs Industry: A241820 underperformed the KR Medical Equipment industry which returned 11.7% over the past year.
Return vs Market: A241820 underperformed the KR Market which returned -4% over the past year.
Price Volatility
| A241820 volatility | |
|---|---|
| A241820 Average Weekly Movement | 9.9% |
| Medical Equipment Industry Average Movement | 6.8% |
| Market Average Movement | 5.6% |
| 10% most volatile stocks in KR Market | 11.5% |
| 10% least volatile stocks in KR Market | 2.7% |
Stable Share Price: A241820's share price has been volatile over the past 3 months compared to the KR market.
Volatility Over Time: A241820's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of KR stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2008 | 31 | Soyeon Kim | www.pclchip.com |
PCL, Inc. provides multiplex in vitro diagnostic (IVD) products and platform services. The company offers HiSU solution, an automated multi-immune diagnostic system that performs various diagnostics, high-speed tests including blood screening, multiple cancer screening, autoimmune testing, etc. It also provides antigen and antibody diagnostic kits, including PCLOK II anti-HIV/HCV/syphilis, and PCLOK II HBsAg/HIV p24. In addition, the company offers platform services, such as SG ID for identifying novel target substances.
PCL, Inc. Fundamentals Summary
| A241820 fundamental statistics | |
|---|---|
| Market cap | ₩39.94b |
| Earnings (TTM) | -₩15.12b |
| Revenue (TTM) | ₩7.83b |
5.1x
P/S Ratio-2.6x
P/E RatioIs A241820 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A241820 income statement (TTM) | |
|---|---|
| Revenue | ₩7.83b |
| Cost of Revenue | ₩11.01b |
| Gross Profit | -₩3.18b |
| Other Expenses | ₩11.94b |
| Earnings | -₩15.12b |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -255.51 |
| Gross Margin | -40.63% |
| Net Profit Margin | -193.10% |
| Debt/Equity Ratio | 33.0% |
How did A241820 perform over the long term?
See historical performance and comparison